Publication | Open Access
The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC
14
Citations
32
References
2021
Year
SCARA5 was silenced in NSCLC due to promoter methylation and could be a potential tumor marker in NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1